TeleTrader 01/10/2025 Europe ends higher with attention on CPI, US politics
TeleTrader 01/10/2025 AstraZeneca jumps 9% after US-Pfizer deal
GlobeNewswire 01/10/2025 Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Ser...
GlobeNewswire 01/10/2025 Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
GlobeNewswire 01/10/2025 Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
TeleTrader 01/10/2025 Europe opens mixed with Eurozone's CPI coming up
GlobeNewswire 29/09/2025 Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the ...
TeleTrader 29/09/2025 GSK picks Luke Miels as CEO
TeleTrader 29/09/2025 AstraZeneca to directly list ordinary shares on NYSE
GlobeNewswire 25/09/2025 AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Ri...
GlobeNewswire 22/09/2025 ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK
GlobeNewswire 17/09/2025 Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Season...
GlobeNewswire 16/09/2025 Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
TeleTrader 15/09/2025 Europe closes mostly higher after data
TeleTrader 13/09/2025 AstraZeneca halts £200M Cambridge investment
GlobeNewswire 09/09/2025 Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program
GlobeNewswire 09/09/2025 With Asthma-Related ER Visits Increasing, AAFA Names 2025 Asthma Capitals
GlobeNewswire 09/09/2025 Scenic Biotech Appoints Dr. Roland W. Bürli as CSO to Advance Pipeline of Modifier Therapies in Neur...
GlobeNewswire 05/09/2025 HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and th...
Newsfile Corp 04/09/2025 Kuehn Law Encourages Investors of Tempus AI, Inc. to Contact Law Firm
GlobeNewswire 03/09/2025 Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2...
GlobeNewswire 03/09/2025 Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anor...
GlobeNewswire 02/09/2025 Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire 02/09/2025 FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
GlobeNewswire 27/08/2025 Quell Therapeutics Establishes World-Class Scientific Advisory Board